Candriam SCA’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-80,000
| Closed | -$8.95M | – | 842 |
|
2019
Q1 | $8.95M | Buy |
+80,000
| New | +$8.95M | 0.11% | 212 |
|
2018
Q1 | – | Sell |
-32,000
| Closed | -$1.87M | – | 796 |
|
2017
Q4 | $1.87M | Buy |
32,000
+17,000
| +113% | +$993K | 0.03% | 469 |
|
2017
Q3 | $871K | Sell |
15,000
-9,500
| -39% | -$552K | 0.02% | 591 |
|
2017
Q2 | $2.97M | Buy |
24,500
+3,000
| +14% | +$363K | 0.06% | 385 |
|
2017
Q1 | $2.43M | Hold |
21,500
| – | – | 0.05% | 404 |
|
2016
Q4 | $2.34M | Hold |
21,500
| – | – | 0.05% | 343 |
|
2016
Q3 | $3.54M | Sell |
21,500
-1,500
| -7% | -$247K | 0.09% | 253 |
|
2016
Q2 | $3.28M | Sell |
23,000
-15,000
| -39% | -$2.14M | 0.09% | 241 |
|
2016
Q1 | $4.86M | Buy |
38,000
+4,200
| +12% | +$537K | 0.12% | 199 |
|
2015
Q4 | $5.05M | Sell |
33,800
-6,000
| -15% | -$896K | 0.14% | 177 |
|
2015
Q3 | $6.6M | Sell |
39,800
-16,200
| -29% | -$2.69M | 0.16% | 162 |
|
2015
Q2 | $13.5M | Buy |
56,000
+7,000
| +14% | +$1.69M | 0.28% | 98 |
|
2015
Q1 | $13.8M | Buy |
49,000
+14,000
| +40% | +$3.95M | 0.28% | 93 |
|
2014
Q4 | $5.46M | Buy |
+35,000
| New | +$5.46M | 0.11% | 217 |
|